Suppr超能文献

心房颤动内分泌调控的新方面及其临床转化的可能性。

New aspects of endocrine control of atrial fibrillation and possibilities for clinical translation.

机构信息

Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Montréal, QC, Canada.

Department of Pharmacology and Physiology/Institute of Biomedical Engineering, Université de Montréal, Montréal, QC, Canada.

出版信息

Cardiovasc Res. 2021 Jun 16;117(7):1645-1661. doi: 10.1093/cvr/cvab080.

Abstract

Hormones are potent endo-, para-, and autocrine endogenous regulators of the function of multiple organs, including the heart. Endocrine dysfunction promotes a number of cardiovascular diseases, including atrial fibrillation (AF). While the heart is a target for endocrine regulation, it is also an active endocrine organ itself, secreting a number of important bioactive hormones that convey significant endocrine effects, but also through para-/autocrine actions, actively participate in cardiac self-regulation. The hormones regulating heart-function work in concert to support myocardial performance. AF is a serious clinical problem associated with increased morbidity and mortality, mainly due to stroke and heart failure. Current therapies for AF remain inadequate. AF is characterized by altered atrial function and structure, including electrical and profibrotic remodelling in the atria and ventricles, which facilitates AF progression and hampers its treatment. Although features of this remodelling are well-established and its mechanisms are partly understood, important pathways pertinent to AF arrhythmogenesis are still unidentified. The discovery of these missing pathways has the potential to lead to therapeutic breakthroughs. Endocrine dysfunction is well-recognized to lead to AF. In this review, we discuss endocrine and cardiocrine signalling systems that directly, or as a consequence of an underlying cardiac pathology, contribute to AF pathogenesis. More specifically, we consider the roles of products from the hypothalamic-pituitary axis, the adrenal glands, adipose tissue, the renin-angiotensin system, atrial cardiomyocytes, and the thyroid gland in controlling atrial electrical and structural properties. The influence of endocrine/paracrine dysfunction on AF risk and mechanisms is evaluated and discussed. We focus on the most recent findings and reflect on the potential of translating them into clinical application.

摘要

激素是多种器官功能的强效内、旁分泌和自分泌内源性调节剂,包括心脏。内分泌功能障碍可促进多种心血管疾病,包括心房颤动(AF)。虽然心脏是内分泌调节的靶器官,但它本身也是一个活跃的内分泌器官,分泌许多重要的生物活性激素,传递重要的内分泌效应,但也通过旁/自分泌作用,积极参与心脏的自我调节。调节心脏功能的激素协同作用,以支持心肌功能。AF 是一种严重的临床问题,与发病率和死亡率增加有关,主要是由于中风和心力衰竭。目前治疗 AF 的方法仍然不足。AF 的特征是心房功能和结构改变,包括心房和心室的电和纤维形成性重塑,这促进了 AF 的进展,并阻碍了其治疗。尽管这种重塑的特征已得到很好的确定,其机制部分得到理解,但与 AF 心律失常发生相关的重要途径仍未确定。发现这些缺失的途径有可能带来治疗突破。内分泌功能障碍被认为是导致 AF 的主要原因。在这篇综述中,我们讨论了直接或作为潜在心脏病理学的结果,导致 AF 发病机制的内分泌和心激素信号系统。更具体地说,我们考虑了来自下丘脑-垂体轴、肾上腺、脂肪组织、肾素-血管紧张素系统、心房肌细胞和甲状腺的产物在控制心房电和结构特性方面的作用。评估和讨论了内分泌/旁分泌功能障碍对 AF 风险和机制的影响。我们专注于最新的发现,并思考将它们转化为临床应用的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f76f/8208746/b3678c992c99/cvab080f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验